- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Obesity and Diabetes Mellitus, Type 2 in Finland
Total 565 results
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States, Austria, Canada, Italy, Netherlands, Spain, United Kingdom, Taiwan, Thailand, Bulgaria, Belgium, Germany, Korea, Republic of, Hungary, Philippines, China, Malaysia, Hong Kong, New Zealand, Argentina, Czechia, Slovakia, Braz... and more
-
Hoffmann-La RocheCompletedCardiovascular Disease, Diabetes Mellitus Type 2Germany, Spain, Korea, Republic of, United States, Colombia, Mexico, Hungary, Canada, Austria, Estonia, Malaysia, Australia, Poland, Thailand, Czech Republic, Latvia, Italy, Romania, Russian Federation, Chile, Lithuania, Sweden, United... and more
-
Wyeth is now a wholly owned subsidiary of PfizerTerminatedDiabetes MellitusChina, United States, Canada, Mexico, Russian Federation, Croatia, United Kingdom, Argentina, Australia, India, South Africa, Greece, Ukraine, Romania, Italy, Hong Kong, Former Serbia and Montenegro, Brazil
-
GlaxoSmithKlineDuke Clinical Research InstituteCompletedDiabetes MellitusUnited States, Argentina, Germany, Poland, Russian Federation, Spain, Taiwan, Czechia, Hungary, Italy, Ukraine, Belgium, Netherlands, South Africa, Sweden, Thailand, Korea, Republic of, Mexico, Bulgaria, Hong Kong, Peru, Philippines, Gree... and more
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusSweden, United States, Australia, Brazil, Czech Republic, Italy, Mexico, Peru, Poland, Russian Federation, South Africa, Spain, United Kingdom, Germany, China, Hungary, Netherlands, Canada, Hong Kong, Argentina, Chile, France, Israel, Puerto Rico and more
-
AstraZenecaCompletedType 2 DiabetesUnited States, Canada, France, Mexico
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States, Peru, Mexico
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Canada, Mexico, Puerto Rico
-
PfizerCompletedDiabetic NephropathyUnited States, Spain, Korea, Republic of, Australia, Hong Kong, Germany, Poland, Italy, Canada, Puerto Rico, Malaysia, Romania, Argentina, Peru
-
Intarcia TherapeuticsCompleted
-
AstraZenecaTerminatedType 2 DiabetesBrazil, France, Russian Federation, South Africa, Germany, Malaysia, Finland, Norway, Hong Kong, Canada, Hungary, Portugal, Taiwan, India, Philippines, Switzerland, Indonesia, Singapore
-
Marjukka KolehmainenKuopio University Hospital; Raisio PlcCompleted
-
AstraZenecaTerminatedType 2 DiabetesUnited States, Brazil, Czech Republic, Italy, Korea, Republic of, Russian Federation, South Africa, United Kingdom, Vietnam, Philippines, Malaysia, Estonia, Latvia, Lithuania, Poland, Finland, Canada, Hong Kong, Argentina, Hun... and more
-
Solvay PharmaceuticalsCompletedType 2 Diabetes | HypogonadismUnited States
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Spain, Italy, United States, Germany, United Kingdom, Russian Federation, Canada, Poland, Puerto Rico, Macedonia, The Former Yugoslav Republic of
-
Turku University HospitalAcademy of FinlandCompleted
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Germany, Poland, Argentina, United Kingdom, Mexico
-
AstraZenecaCompletedType 2 DiabetesMexico, United States, Poland, Canada, Russian Federation, South Africa, France, Hungary, India, United Kingdom
-
Marmara UniversityUniversity of TurkuCompletedDiabetes Mellitus, Type 2 | PeriodontitisFinland, Turkey
-
Mylan Inc.Mylan GmbHCompletedType 2 DiabetesUnited States, Jordan, Korea, Republic of, Slovakia, South Africa, Taiwan
-
University Medical Center GroningenJuvenile Diabetes Research Foundation; Lexicon PharmaceuticalsNot yet recruitingType 1 Diabetes Mellitus With Diabetic NephropathyNetherlands, United States, Canada, Denmark, Finland
-
AstraZenecaTerminatedType 2 DiabetesUnited States, Brazil, Czech Republic, France, Italy, Korea, Republic of, Poland, Russian Federation, South Africa, Spain, United Kingdom, Vietnam, Germany, Philippines, Malaysia, Sweden, Estonia, Latvia, Lithuania, Finland, Norway and more
-
Eli Lilly and CompanyRecruitingType 2 DiabetesUnited States, Argentina, United Kingdom, Puerto Rico
-
TakedaEli Lilly and CompanyCompletedDiabetes MellitusUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesPoland, Spain, Germany, Finland, France
-
SanofiCompletedType 2 DiabetesUnited States, Canada, Chile, Czech Republic, Estonia, France, Germany, Hungary, Italy, Latvia, Lithuania, Mexico, Poland, Romania, Russian Federation, Spain, Ukraine, United Kingdom
-
University of OuluTurku University Hospital; Oulu University Hospital; Tampere University HospitalEnrolling by invitation
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Poland, Russian Federation, Germany, Italy, Netherlands, Spain, Sweden, Argentina, Denmark, Finland, Hungary, Norway, Colombia, Austria, Greece, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Romania, Slovakia, Israel, Saudi Arabia, India, Malaysia, Mexico, Russian Federation, Germany, Croatia, Poland, Serbia, Bulgaria, Canada, Slovenia, Sweden, Denmark, Hungary, Argentina, Austria, Finland, Lebanon, Czechia, Netherlands
-
Novartis PharmaceuticalsTerminatedCardiovascular Disease | Type 2 Diabetes MellitusSpain, China, United States, Belgium, Colombia, South Africa, Italy, United Kingdom, Germany, Hungary, Japan, Taiwan, Turkey, Netherlands, Greece, Switzerland, Austria, France, Thailand, Argentina, Canada, Singapore, Lithuania, Sweden, ... and more
-
Helsinki University Central HospitalGöteborg UniversityCompleted
-
Boehringer IngelheimActive, not recruitingObesity | Diabetes Mellitus, Type 2Spain, United States, Korea, Republic of, Belgium, Australia, China, Poland, Japan, Finland, Germany, Greece, Canada, Hungary, New Zealand, Sweden, United Kingdom, Netherlands, Czechia, Denmark
-
TakedaCompletedDiabetes MellitusUnited States, Argentina, Canada, Chile
-
PfizerTerminatedDiabetes Mellitus Type 2Spain, Canada, France, Greece, Portugal, Sweden, Turkey
-
SanofiCompletedDiabetes Mellitus, Type 2Korea, Republic of, Russian Federation, Spain, Denmark, Canada, Germany, Ireland, Portugal, Australia, India, Turkey, Netherlands, Sweden, United Kingdom, Finland, Switzerland, Romania, Brazil, Serbia, Taiwan
-
Novo Nordisk A/SWithdrawnDiabetes Mellitus, Type 2United States, Sweden, Austria, Finland
-
Novo Nordisk A/SRecruitingType 2 DiabetesUnited States, Taiwan, Australia, Hungary, Germany, India, Canada, Spain, Czechia, Argentina, Poland, Colombia, South Africa, France, Greece, Romania
-
University of OuluTurku University Hospital; Oulu University Hospital; Tampere University Hospital and other collaboratorsCompleted
-
University of OuluTurku University Hospital; Oulu University Hospital; Tampere University Hospital and other collaboratorsCompleted
-
Turku University HospitalUniversity of TurkuCompletedLiver Diseases | Obesity | Pregnancy | Neurodevelopmental Disorders | Type2 Diabetes | Adiposity | Cardiovascular Risk Factor | Gestational Diabetes Mellitus | Eating Behavior | Cognitive Developmental DisordersFinland
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Austria, Argentina, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, Denmark, Ecuador, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Italy, Malaysia, Mexico, Netherlands, Norway, Peru, Poland, Russian Federation and more
-
TakedaTerminatedCardiovascular Disease | Type 2 DiabetesUnited States, France, Poland, Ukraine, Germany, Hong Kong, Taiwan, Argentina, Israel, Mexico, Bulgaria, Malaysia, Romania, Canada, Korea, Republic of, New Zealand, Peru, Estonia, Philippines, Russian Federation, Czech Republic, H... and more
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesMalaysia, Australia, Taiwan, Thailand, Hong Kong, Singapore, Philippines
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesAustralia, United States, Canada, Mexico, Puerto Rico, Germany, Hungary, Ireland, Poland, Romania, Denmark, Czech Republic, India, Colombia, Finland, United Kingdom
-
SanofiTerminatedDiabetes Mellitus, Type 2United States, Romania, Russian Federation, Spain, Sweden, India, Mexico, Denmark, Finland, Hungary, Italy, Korea, Republic of, Chile, Puerto Rico
-
The Miriam HospitalBrown University; Tufts Medical CenterCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Spain, Denmark, Austria, Belgium, Serbia, Germany, Canada, France, Finland, Norway, Czech Republic
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Denmark, Sweden, Malaysia, Poland, Turkey, Finland, Australia, Thailand, Taiwan